 I was recently invited back on to the Capital Employed Podcast to have another chat with Jon Kingston. We chatted about recent developments at MYX.L and I pitched the tiny AIM listed firm HDT.L.
You can listen to the show on Spotify, Youtube, Apple Podcasts and Google Podcasts. Cheers, David Disclosure: Long MYX.L and HDT.L
0 Comments
 Holders Technology PLC (HDT.L) is selling below liquidation value and building a base on the long-range chart. It's only a matter of time before the stock begins to break out and I'll be there when it does.  Most of my investment decisions happen very quickly now. It's rare that I labour over an idea to figure out if it's a buy or not. Tricorn PLC (TCN.L) is no different to the rest,
Everything lines up; The market cap, share price, public float, price chart and situation. All just how I want them.  Learning Tree International Inc (LTRE) issued its last financials in late 2018 and then went dark in early 2019. Since then there's been very few updates regarding the company's fortunes other than the occasional news release on their website. The market hates uncertainty and the stock price has responded in kind.
 PASSUR Aerospace Inc. (PSSR) is at a multi-year low on the long-range price chart and the market is not interested in it.
Worth a look.  MyCelex Technologies Corp (MYX:LON) is currently sat way down on the long range price chart and selling at a discount to tangible assets, that's enough to get me interested.
 I was recently invited on to the Capital Employed Podcast to have a chat with Jon Kingston. We talked a little about my style of investing and then I pitched the tiny AIM listed company MyCelx Technologies Corp (MYX.LON).
You can listen to the show on Spotify, Youtube, Apple Podcasts and Google Podcasts. Cheers, David Disclosure: Long MYX.L  I initially bought ECC Capital Corp (ECRO) back in February of this year after a much smarter investor than myself told me about it (Thanks Bill, you totally nailed it!).
 I'm happy to announce that the Svenda's Manual of OTC stocks database is now available for an annual subscription price of $179.
 In a former life ImmunoCellular Therapeutics Ltd (IMUC) was a biotechnology company focusing on cancer immunotherapy, now its just a cash shell with some potential.
|
David J. FloodUK based Investor. I focus Archives
June 2021
Categories
All
BLOGS I FOLLOW
No Name Stocks Svenda's Manual of OTC Stocks Caveat Emptor Stocks Leaven Partners OTC Adventures Nothing But Net Nets Clark Street Value Value Investing Blog Alpha Vulture Deep Value Investments OddballStocks Value Stock Geek Barel Karsan - Value Investing Shadow Stock Hidden Value Yet Another Value Blog Streets Of Value TES Optimal Value Investing The Bad Investor Undervalued Japan Liquidation Almanac Adventures in Capitalism White Chip Stocks Light Blue Value Global Investing Insight Mesaba Range Value The Market Plunger Neto's Notes Battleship Investing Blog The Investment Long-List Oceania Value Riley Newport Grahamian Value Digest Stock Speaking Canadian Value Stocks Analyzing Bargain Stocks MicroValue Hidden Gem Investing |
RSS Feed